90-year-old Margaret: ‘I feel so privileged to be first person vaccinated against COVID-19’
A nurse rolled up 90-year-old Margaret Keenan’s sleeve and administered a shot watched round the world — the first jab in the UK’s COVID-19 vaccination program kicking off an unprecedented global effort to try to end a pandemic that has killed 1.5 million people, according to The Associated Press.
Keenan, a retired shop clerk from Northern Ireland who celebrates her birthday next week, was at the front of the line at University Hospital Coventry to receive the vaccine that was approved by British regulators last week.
The UK is the first Western country to deliver a broadly tested and independently reviewed vaccine to the general public, according to The Associated Press.
The COVID-19 shot was developed by US drugmaker Pfizer and Germany’s BioNTech. US and European Union regulators may approve it in the coming days or weeks.
“All done?” Keenan asked nurse May Parsons. “All done,” came the reply, as hospital staff broke into applause and also clapped for her as she was wheeled down a corridor.
“I feel so privileged to be the first person vaccinated against COVID-19,” said Keenan, who wore a surgical mask and a blue “Merry Christmas” T-shirt with a cartoon penguin in a Santa hat.
“It’s the best early birthday present I could wish for because it means I can finally look forward to spending time with my family and friends in the New Year after being on my own for most of the year.”
The second injection, in a fitting bit of drama, went to an 81-year-old man named William Shakespeare from Warwickshire, the county where the bard was born, according to The Associated Press.
The fanfare was good cheer to the nation, if but for a moment.
Authorities warned that the vaccination campaign would take many months, meaning painful restrictions that have disrupted daily life and punished the economy are likely to continue until spring.
“This really feels like the beginning of the end,″ said Stephen Powis, medical director for the National Health Service in England.
“It’s been a really dreadful year, 2020 — all those things that we are so used to, meeting friends and family, going to the cinema, have been disrupted. We can get those back. Not tomorrow. Not next week. Not next month. But in the months to come.″
But it is important beyond these shores. Britain’s program is likely to provide lessons for other countries as they prepare for the unprecedented task of vaccinating billions.
On Saturday, Russia began vaccinations with its Sputnik V vaccine, and China has also begun giving its own domestically made shots to its citizens and selling them abroad.
But those are being viewed differently because neither countries’ vaccines have finished the late-stage trials scientists consider essential for proving a serum is safe and effective.
Other vaccines are also being reviewed by regulators around the world, including a collaboration between Oxford University and drugmaker AstraZeneca and one developed by US biotechnology company Moderna.
Documents released by US regulators Tuesday confirmed that Pfizer’s vaccine was strongly protective against COVID-19 and appeared safe.
New results on a possible vaccine from Oxford University and drugmaker AstraZeneca suggest it is safe and about 70% effective, according to early test results from Britain and Brazil. But that report, in the medical journal Lancet, showed that questions remain about how well it helps protect those over 55.